{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:47:23Z","timestamp":1791233243393,"version":"4.1.0"},"reference-count":46,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T00:00:00Z","timestamp":1739750400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,16]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Utilization of glucagon-like peptide-1 receptor agonists (GLP-1ras) has increased dramatically in recent years. Although GLP-1ras appear safe to use overall, it remains unclear whether preoperative GLP-1ra use impacts body contouring surgery outcomes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>This study evaluates the postoperative course of patients receiving body contouring procedures by GLP-1ra use.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This retrospective cohort study examined patients who received panniculectomies, brachioplasties, thighplasties, and abdominoplasties at a large academic institution between November 2014 and November 2024. Propensity score\u2013matched analysis paired cohorts by age, smoking status, and BMI and hemoglobin A1c at the time of surgery. Univariate analyses and multivariable logistic regression were performed.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>In total, 590 patients were included in this study. Of these, 100 patients utilized GLP-1ras before surgery. Propensity score\u2013matched analysis paired 72 GLP-1ra and 143 non-GLP-1ra patients. Thirty day readmissions and emergency department visits in matched and unmatched cohorts were similar by GLP-1ra use (P &amp;gt; .05). Postoperative cellulitis occurred less frequently among GLP-1ra users in matched cohorts (P = .008); however, GLP-1ra use status did not predict cellulitis on multivariable logistic regression. Duration of GLP-1ra use and timing of discontinuation before surgery did not predict the incidence of wound dehiscence, seromas, or hematomas. Patients using GLP-1ras for obesity had lower rates of wound dehiscence than patients using GLP-1ras for diabetes (P = .028).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Compared with non-GLP-1ra controls, GLP-1ra users have similar postoperative outcomes following body contouring surgery. Wound dehiscence is more prevalent among patients taking GLP-1ras for diabetes compared with weight loss, potentially because of worse glycemic control or associated comorbidities.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Level of Evidence: 3 (Therapeutic)<\/jats:title>\n                  <jats:p\/>\n               <\/jats:sec>","DOI":"10.1093\/asj\/sjaf029","type":"journal-article","created":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T17:54:32Z","timestamp":1739814872000},"page":"501-507","source":"Crossref","is-referenced-by-count":13,"title":["Postoperative Outcomes in Body Contouring Procedures Following Glucagon-Like Peptide-1 Receptor Agonist Use: A 10-Year Analysis"],"prefix":"10.1093","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8510-3839","authenticated-orcid":false,"given":"Joey","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara","family":"Pillai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakshi","family":"Chopra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jackson M","family":"Cathey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ash","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,2,17]]},"reference":[{"key":"2025041606515881600_sjaf029-B1","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1093\/asj\/sjad211","article-title":"Public interest in the off-label use of glucagon-like peptide 1 agonists (ozempic) for cosmetic weight loss: a google trends analysis","volume":"44","author":"Han","year":"2023","journal-title":"Aesthet Surg J"},{"key":"2025041606515881600_sjaf029-B2","doi-asserted-by":"publisher","first-page":"e5516","DOI":"10.1097\/GOX.0000000000005516","article-title":"Injectable weight loss medications in plastic surgery: what we know, perioperative considerations, and recommendations for the future","volume":"12","author":"O\u2019Neill","year":"2024","journal-title":"Plast Reconstr Surg Glob Open"},{"key":"2025041606515881600_sjaf029-B3","doi-asserted-by":"publisher","first-page":"NP279","DOI":"10.1093\/asj\/sjad364","article-title":"Practice patterns and perspectives of the off-label use of GLP-1 agonists for cosmetic weight loss","volume":"44","author":"Han","year":"2024","journal-title":"Aesthet Surg J"},{"key":"2025041606515881600_sjaf029-B4","doi-asserted-by":"publisher","first-page":"NP125","DOI":"10.1093\/asj\/sjad160","article-title":"Expanding medicare part D coverage of weight loss medications: the impact on plastic surgery","volume":"44","author":"Das","year":"2024","journal-title":"Aesthet Surg J"},{"key":"2025041606515881600_sjaf029-B5","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/s41392-024-01931-z","article-title":"Glucagon-like peptide-1 receptor: mechanisms and advances in therapy","volume":"9","author":"Zheng","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"2025041606515881600_sjaf029-B6","doi-asserted-by":"publisher","first-page":"e076410","DOI":"10.1136\/bmj-2023-076410","article-title":"Comparative effectiveness of GLP-1 receptor agonists on glycaemic control, body weight, and lipid profile for type 2 diabetes: systematic review and network meta-analysis","volume":"384","author":"Yao","year":"2024","journal-title":"BMJ"},{"key":"2025041606515881600_sjaf029-B7","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/S2213-8587(21)00203-5","article-title":"Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials","volume":"9","author":"Sattar","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2025041606515881600_sjaf029-B8"},{"key":"2025041606515881600_sjaf029-B9","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"N Engl J Med"},{"key":"2025041606515881600_sjaf029-B10","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1093\/asj\/sjae166","article-title":"Navigating the evolving roles of GLP-1 agonists safely and effectively","volume":"44","author":"Ockerman","year":"2024","journal-title":"Aesthet Surg J"},{"key":"2025041606515881600_sjaf029-B11","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/jcpt.13230","article-title":"A review of GLP-1 receptor agonists in type 2 diabetes: a focus on the mechanism of action of once-weekly agents","volume":"45","author":"Cornell","year":"2020","journal-title":"J Clin Pharm Ther"},{"key":"2025041606515881600_sjaf029-B12","doi-asserted-by":"publisher","first-page":"100456","DOI":"10.1016\/j.obmed.2022.100456","article-title":"Effects of GLP-1 agonists on proportion of weight loss in obesity with or without diabetes: systematic review and meta-analysis","volume":"35","author":"Vosoughi","year":"2022","journal-title":"Obes Med"},{"key":"2025041606515881600_sjaf029-B13","doi-asserted-by":"publisher","first-page":"NP177","DOI":"10.1093\/asj\/sjad304","article-title":"Current weight loss medications: what plastic surgeons should know","volume":"44","author":"Wirth","year":"2024","journal-title":"Aesthet Surg J"},{"key":"2025041606515881600_sjaf029-B14","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1093\/asj\/sjad240","article-title":"The emerging role of injectable weight loss medications in plastic surgery: a systematic review","volume":"44","author":"Shridharani","year":"2023","journal-title":"Aesthet Surg J"},{"key":"2025041606515881600_sjaf029-B15","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1055\/a-2148-6321","article-title":"Implications of ozempic and other GLP-1 receptor agonists for facial plastic surgeons","volume":"39","author":"Humphrey","year":"2023","journal-title":"Facial Plast Surg"},{"key":"2025041606515881600_sjaf029-B16","doi-asserted-by":"publisher","first-page":"NP809","DOI":"10.1093\/asj\/sjae132","article-title":"Decoding the implications of glucagon-like peptide-1 receptor agonists on accelerated facial and skin aging","volume":"44","author":"Ridha","year":"2024","journal-title":"Aesthet Surg J"},{"key":"2025041606515881600_sjaf029-B17","doi-asserted-by":"publisher","first-page":"100121","DOI":"10.1016\/j.obpill.2024.100121","article-title":"Dietary intake by patients taking GLP-1 and dual GIP\/GLP-1 receptor agonists: a narrative review and discussion of research needs","volume":"11","author":"Christensen","year":"2024","journal-title":"Obes Pillars"},{"key":"2025041606515881600_sjaf029-B18","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.jpra.2024.01.006","article-title":"Impact of nutrition on skin wound healing and aesthetic outcomes: a comprehensive narrative review","volume":"39","author":"Seth","year":"2024","journal-title":"JPRAS Open"},{"key":"2025041606515881600_sjaf029-B19","doi-asserted-by":"publisher","first-page":"629e","DOI":"10.1097\/PRS.0000000000011418","article-title":"Emerging role of semaglutide and GLP-1 agonist medications in plastic surgery: a note of caution","volume":"154","author":"Borab","year":"2024","journal-title":"Plast Reconstr Surg"},{"key":"2025041606515881600_sjaf029-B20","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1093\/asj\/sjae085","article-title":"Prevalence patterns of body contouring procedures among injectable glucagon-like peptide-1 receptor agonist users","volume":"44","author":"Toms","year":"2024","journal-title":"Aesthet Surg J"},{"key":"2025041606515881600_sjaf029-B21","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1093\/asj\/sjae241","article-title":"Semaglutide and postoperative outcomes in nondiabetic patients following body contouring surgery","volume":"45","author":"Lewis","year":"2025","journal-title":"Aesthet Surg J"},{"key":"2025041606515881600_sjaf029-B22","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1093\/asj\/sjv087","article-title":"Combining abdominal and cosmetic breast surgery does not increase short-term complication rates: a comparison of each individual procedure and pretreatment risk stratification tool","volume":"35","author":"Khavanin","year":"2015","journal-title":"Aesthet Surg J"},{"key":"2025041606515881600_sjaf029-B23","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1093\/asj\/sjx012","article-title":"Rates and predictors of readmission following body contouring procedures: an analysis of 5100 patients from the national surgical quality improvement program database","volume":"37","author":"Vieira","year":"2017","journal-title":"Aesthet Surg J"},{"key":"2025041606515881600_sjaf029-B24","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1097\/PRS.0000000000011179","article-title":"The impact of body mass index on adverse outcomes associated with panniculectomy: a multimodal analysis","volume":"154","author":"Laspro","year":"2024","journal-title":"Plast Reconstr Surg"},{"key":"2025041606515881600_sjaf029-B25","doi-asserted-by":"publisher","first-page":"e3955","DOI":"10.1097\/GOX.0000000000003955","article-title":"Abdominal panniculectomy: an analysis of outcomes in 238 consecutive patients over 10 years","volume":"9","author":"Kuruoglu","year":"2021","journal-title":"Plast Reconstr Surg Glob Open"},{"key":"2025041606515881600_sjaf029-B26"},{"key":"2025041606515881600_sjaf029-B27","doi-asserted-by":"publisher","first-page":"e086424","DOI":"10.1136\/bmjopen-2024-086424","article-title":"Effectiveness of glucagon-like peptide-1 receptor agonists for reduction of body mass index and blood glucose control in patients with type 2 diabetes mellitus and obesity: a retrospective cohort study and difference-in-difference analysis","volume":"14","author":"Siriyotha","year":"2024","journal-title":"BMJ Open"},{"key":"2025041606515881600_sjaf029-B28","doi-asserted-by":"publisher","DOI":"10.1111\/dom.16136","article-title":"Anti-diabetic effects of GLP-1 receptor agonists on obese and overweight patients across diabetes status, administration routes, treatment duration and baseline characteristics: a systematic review","author":"Wong","year":"2024","journal-title":"Diabetes Obes Metab"},{"key":"2025041606515881600_sjaf029-B29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v042.i08","article-title":"Matchit: nonparametric preprocessing for parametric causal inference","volume":"42","author":"Ho","year":"2011","journal-title":"J Stat Softw"},{"key":"2025041606515881600_sjaf029-B30","doi-asserted-by":"publisher","first-page":"e4003","DOI":"10.1097\/GOX.0000000000004003","article-title":"Propensity scoring in plastic surgery research: an analysis and best practice guide","volume":"10","author":"Chu","year":"2022","journal-title":"Plast Reconstr Surg Glob Open"},{"key":"2025041606515881600_sjaf029-B31"},{"key":"2025041606515881600_sjaf029-B32","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1016\/j.soard.2024.08.033","article-title":"Multisociety clinical practice guidance for the safe use of glucagon-like peptide-1 receptor agonists in the perioperative period","volume":"20","author":"Kindel","year":"2024","journal-title":"Surg Obes Relat Dis"},{"key":"2025041606515881600_sjaf029-B33","doi-asserted-by":"publisher","first-page":"116119","DOI":"10.1016\/j.amjsurg.2024.116119","article-title":"A systematic review of the use of GLP-1 receptor agonists in surgery","volume":"240","author":"Ihnat","year":"2025","journal-title":"Am J Surg"},{"key":"2025041606515881600_sjaf029-B34","doi-asserted-by":"publisher","first-page":"luad067","DOI":"10.1210\/jcemcr\/luad067","article-title":"Meeting the body mass index requirement for gender-affirming surgery using antiobesity medication","volume":"1","author":"Taormina","year":"2023","journal-title":"JCEM Case Rep"},{"key":"2025041606515881600_sjaf029-B35"},{"key":"2025041606515881600_sjaf029-B36","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000006614","article-title":"Association of perioperative glucagon-like peptide-1 receptor agonist use and postoperative outcomes","author":"Aschen","year":"2024","journal-title":"Ann Surg"},{"key":"2025041606515881600_sjaf029-B37","doi-asserted-by":"publisher","first-page":"348","DOI":"10.2106\/JBJS.24.00468","article-title":"Glucagon-like peptide-1 receptor agonists decrease medical and surgical complications in morbidly obese patients undergoing primary TKA","volume":"107","author":"Kim","year":"2025","journal-title":"J Bone Joint Surg Am"},{"key":"2025041606515881600_sjaf029-B38","doi-asserted-by":"publisher","first-page":"367","DOI":"10.2337\/dc19-1393","article-title":"Glycemic control and risk of cellulitis","volume":"44","author":"Zacay","year":"2021","journal-title":"Diabetes Care"},{"key":"2025041606515881600_sjaf029-B39","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1055\/s-0041-1731460","article-title":"Updates in diabetic wound healing, inflammation, and scarring","volume":"35","author":"Dasari","year":"2021","journal-title":"Semin Plast Surg"},{"key":"2025041606515881600_sjaf029-B40","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/wrr.12694","article-title":"Diabetes is associated with an increased risk of wound complications and readmission in patients with surgically managed pressure ulcers","volume":"27","author":"Alfonso","year":"2019","journal-title":"Wound Repair Regen"},{"key":"2025041606515881600_sjaf029-B41","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/micr.30332","article-title":"Diabetes is not associated with increased rates of free flap failure: analysis of outcomes in 6030 patients from the ACS-NSQIP database","volume":"39","author":"Kantar","year":"2019","journal-title":"Microsurgery"},{"key":"2025041606515881600_sjaf029-B42","doi-asserted-by":"publisher","first-page":"462e","DOI":"10.1097\/PRS.0000000000004732","article-title":"Abdominal panniculectomy: determining the impact of diabetes on complications and risk factors for adverse events","volume":"142","author":"Kantar","year":"2018","journal-title":"Plast Reconstr Surg"},{"key":"2025041606515881600_sjaf029-B43","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1007\/s00266-023-03258-6","article-title":"The impact of diabetes mellitus on breast reconstruction outcomes and complications: a systematic literature review and meta-analysis","volume":"47","author":"Mortada","year":"2023","journal-title":"Aesthetic Plast Surg"},{"key":"2025041606515881600_sjaf029-B44","doi-asserted-by":"publisher","first-page":"9509","DOI":"10.1007\/s00464-023-10387-1","article-title":"Use of GLP-1 agonists in high risk patients prior to bariatric surgery: a cohort study","volume":"37","author":"Ilanga","year":"2023","journal-title":"Surg Endosc"},{"key":"2025041606515881600_sjaf029-B45","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1097\/SAP.0000000000004089","article-title":"Glucagon-like peptide-1 agonists: a practical overview for plastic and reconstructive surgeons","volume":"94","author":"Stanton","year":"2025","journal-title":"Ann Plast Surg"},{"key":"2025041606515881600_sjaf029-B46"}],"container-title":["Aesthetic Surgery Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/asj\/advance-article-pdf\/doi\/10.1093\/asj\/sjaf029\/61932666\/sjaf029.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/asj\/article-pdf\/45\/5\/501\/61932666\/sjaf029.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/asj\/article-pdf\/45\/5\/501\/61932666\/sjaf029.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T10:52:01Z","timestamp":1744800721000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/asj\/article\/45\/5\/501\/8019635"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,17]]},"references-count":46,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,2,17]]},"published-print":{"date-parts":[[2025,4,16]]}},"URL":"https:\/\/doi.org\/10.1093\/asj\/sjaf029","relation":{},"ISSN":["1090-820X","1527-330X"],"issn-type":[{"value":"1090-820X","type":"print"},{"value":"1527-330X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,5]]},"published":{"date-parts":[[2025,2,17]]}}}